GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oxurion OXUR.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

0.00

0.00%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Oxurion — daily OXUR

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Oxurion on TradingView ↗
Market value
€2,554
Last close × shares
Volume
6.9m
Shares, 9 Nov 2026

About Oxurion

Its shares trade on Euronext Brussels under the ticker OXUR.BR. It has been listed since 7 July 2006. In the fiscal year to 31 December 2025, it reported revenue of €555,000 and a net loss of €3.7m. At that date it held total assets of €3.8m and shareholders' equity of −€12.9m.

Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. The company is headquartered in Heverlee, Vlaams-Brabant. The company went IPO on 2006-07-07. Its lead product, JETREA (ocriplasmin), has been approved by the United States Food and Drug Administration for the treatment of symptomatic vitreomacular adhesion (VMA) and was launched in January 2013. Oxurion partners with Alcon (Novartis) for the commercialization of JETREA outside the United States. In Europe, JETREA is approved for the treatment of vitreomacular traction (VMT), including when associated with macular hole of diameter less than or equal to 400 microns, which was launched in the United Kingdom and Germany. In addition, it also explores anti-PIGF (Placental Growth Factor), also referred to as TB-403, for the treatment of ophthalmic and oncology indications. The firm is active domestically, as well as operates through offices located in the United States and Ireland.

Figures and description from our data supplier, not checked against the company's own report.

More about Oxurion →

Latest on Oxurion

Our reporting

We have not reported on Oxurion yet.

Next results

3 Mar 2027

Due on 3 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Oxurion's ticker?

Oxurion trades as OXUR.BR on Euronext Brussels, under ISIN BE0974487192.

What was Oxurion's last closing price?

0.00 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Oxurion next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.